Recruiting nowPhase 2
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
Updated 2026-01-13 · NCT06802081See eligibility →
Condition
Active public studies that list Atrial Fibrillation as a condition.
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.